5Cisneros JM, Reyes MJ, Pachon J, et al.Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features[J].Clin Infect Dis, 1996, 22(6): 1026-1032.
6Rodriguez BJ, Pascual A, Galvez J, et al.Acinetobacter baumannii bacteremia: clinical and prognostic features[J].Enferm Infect Microbiol Clin, 2003, 21(5): 242-247.
7Ayan M, Durmaz R, Aktas E, et al.Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter baumannii infection in a teaching hospital[J].J Hosp Infect, 2003, 54(1): 39-45.
8Donald HM, Scaife W, Amyes SG, et al.Sequence analysis of ARI-1, a novel OXA beta-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92[J].Antimicrob Agents Chemother, 2000, 44(1): 196-199.
9Hanes SD,Demirkan K,Tolley E,et al.Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients.Clin Infect Dis,2002,35:228 -235.
10American Thoracic Society.Infectious Diseases Society of America.Guidelines for the management of adults with HAP,VAP,and HCAP.Am J Respir Crit Care Med,2005,171:388 -416.
